35 related articles for article (PubMed ID: 38748324)
1. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [
Liang X; Yang C; Su M; Zou L
Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218
[TBL] [Abstract][Full Text] [Related]
2. The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
Arslantaş E; Ayçiçek A; Esen Akkas B; Tahtakesen Güçer TN; Okur Acar S; Özkan Karagenc A; Akpınar Tekgündüz S; Bayram C
Nuklearmedizin; 2024 Jun; 63(3):207-212. PubMed ID: 38190995
[TBL] [Abstract][Full Text] [Related]
3. Role of 2-(fluorine-18) Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Initial Staging and Bone Marrow Involvement Prediction in Patients with Newly Diagnosed Lymphoma in Correlation with Bone Marrow Study.
Krishna S; Ravina M; Nanda S; Lukose TT; Moideen A; Bansal H; Dasgupta S; Kote R
Indian J Nucl Med; 2024; 39(1):10-17. PubMed ID: 38817719
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma.
Zhao Z; Yang C
Clin Exp Metastasis; 2024 Apr; ():. PubMed ID: 38609536
[TBL] [Abstract][Full Text] [Related]
5. Is bone marrow biopsy and aspiration still mandatory when 18F-FDG PET/CT is available for the initial assessment of bone marrow metastasis in pediatric Ewing sarcoma?
Du Y; Zhao Z; Yang C
Front Oncol; 2024; 14():1372481. PubMed ID: 38800377
[TBL] [Abstract][Full Text] [Related]
6. Correction: Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma.
Zhao Z; Yang C
Clin Exp Metastasis; 2024 Jun; ():. PubMed ID: 38856865
[No Abstract] [Full Text] [Related]
7.
Bashank N; Sharef S; Mohran TZ; Khalil M
EJNMMI Rep; 2024 Apr; 8(1):8. PubMed ID: 38748324
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Kandeel AA; Hussein M; Zidan L; Younis J; Edesa W; Alsayed Y
Nucl Med Commun; 2020 Mar; 41(3):269-279. PubMed ID: 31895758
[TBL] [Abstract][Full Text] [Related]
9. Italian Multicenter Study on Accuracy of
Cistaro A; Cassalia L; Ferrara C; Quartuccio N; Evangelista L; Bianchi M; Fagioli F; Bisi G; Baldari S; Zanella A; Pillon M; Zucchetta P; Burei M; Sala A; Guerra L; Guglielmo P; Burnelli R; Panareo S; Scalorbi F; Rambaldi I; Piccardo A; Garaventa A; Familiari D; Fornito MC; Lopci E; Mascarin M; Altini C; Ferrari C; Perillo T; Santoro N; Borsatti E; Rubini G
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e267-e273. PubMed ID: 29739722
[TBL] [Abstract][Full Text] [Related]
10. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
Chen S; Wang S; He K; Ma C; Fu H; Wang H
Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
[TBL] [Abstract][Full Text] [Related]
11. Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography.
Vishnu P; Wingerson A; Lee M; Mandelson MT; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):631-636. PubMed ID: 28684378
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of
Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L
Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199
[TBL] [Abstract][Full Text] [Related]
13. Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
Radford J; Illidge T; Counsell N; Hancock B; Pettengell R; Johnson P; Wimperis J; Culligan D; Popova B; Smith P; McMillan A; Brownell A; Kruger A; Lister A; Hoskin P; O'Doherty M; Barrington S
N Engl J Med; 2015 Apr; 372(17):1598-607. PubMed ID: 25901426
[TBL] [Abstract][Full Text] [Related]
14. Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma.
Cerci JJ; Györke T; Fanti S; Paez D; Meneghetti JC; Redondo F; Celli M; Auewarakul C; Rangarajan V; Gujral S; Gorospe C; Campo MV; Chung JK; Morris TP; Dondi M; Carr R;
J Nucl Med; 2014 Oct; 55(10):1591-7. PubMed ID: 25214642
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of (18)F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin's Lymphoma.
Lee Y; Hwang KH; Hong J; Park J; Lee JH; Ahn JY; Kim JH; Lee H; Kim SG; Shin JY
Nucl Med Mol Imaging; 2012 Dec; 46(4):269-77. PubMed ID: 24900074
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.
Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Nievelstein RA
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):565-74. PubMed ID: 24281821
[TBL] [Abstract][Full Text] [Related]
17. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
18. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement.
Khan AB; Barrington SF; Mikhaeel NG; Hunt AA; Cameron L; Morris T; Carr R
Blood; 2013 Jul; 122(1):61-7. PubMed ID: 23660958
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
